As President Joe Biden and the U.S. government go all-in on hyping transgender treatments for minors, the U.K. is reportedly retreating from such measures, with new guidance revealing a stunning evolution.
A new Telegraph story details how England’s National Health Service is embracing a radically different idea: childhood transgender identity generally doesn’t extend into adulthood.
The outlet encouraged doctors in its draft guidance to recognize such ideology could simply be a “transient phase,” and young, pre-pubescent children should be treated based on “evidence that, in most cases, gender incongruence does not persist into adolescence.”
The document also addressed concerns over puberty-blocking drugs, which critics allege have little to no research shedding light on potential ramifications. Based on the text, the U.K. will move to more closely monitor these drugs in research settings.